Research indicates that rhinosinusitis affects 5-12% of the global population, and among those with chronic rhinosinusitis, 25-30% also have nasal polyps. Often, rhinosinusitis is accompanied by nasal polyps—benign growths that […]
Deepen your understanding of pharmacological treatment as a cornerstone of effective tobacco treatment. This session explores the neurobiological basis of nicotine dependence and provides a comprehensive review of current clinical […]
Strengthen your ability to engage and support patients through Motivational Interviewing (MI), a powerful, evidence-based approach to supporting tobacco cessation. Participants will gain an understanding of the core principles and […]
INHALE prepares regular PO and Clinical level newsletters that contain:
Arbor Lakes Building 3, Floor 3
4251 Plymouth Rd.
Ann Arbor, MI 48105
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.
